Dr. Chauncey W. Crandall, author of Dr. Crandall’s Heart Health Report newsletter, is chief of the Cardiac Transplant Program at the world-renowned Palm Beach Cardiovascular Clinic in Palm Beach Gardens, Fla. He practices interventional, vascular, and transplant cardiology. Dr. Crandall received his post-graduate training at Yale University School of Medicine, where he also completed three years of research in the Cardiovascular Surgery Division. Dr. Crandall regularly lectures nationally and internationally on preventive cardiology, cardiology healthcare of the elderly, healing, interventional cardiology, and heart transplants. Known as the “Christian physician,” Dr. Crandall has been heralded for his values and message of hope to all his heart patients.

Tags: drug-resistant high blood pressure | high blood pressure control | renal deactivation | hypertension | kidneys and high blood pressure | Dr. Chauncey Crandall

New Help for Hypertension

Wednesday, 25 April 2012 09:50 AM

Participant enrollment is under way at 90 medical centers around the country for testing of a novel, minimally invasive way to treat drug-resistant high blood pressure.

The procedure is targeted at people who are unable to bring their blood pressure under control despite taking up three to five medications.

The clinical trials are designed to evaluate a procedure known as “renal deactivation.” The procedure deactivates certain nerves in the kidneys that are responsible for raising blood pressure.

These nerves are part of the body’s feedback system. When they sense the blood flow to the kidneys is inadequate, they signal the body to raise the blood pressure and increase the flow of blood.

The device under trial uses an arterial renal catheter. The procedure is already being used in Europe and Australia, and this phase III trial is the final step in the Food and Drug Administration’s approval process.

If the tests go well, the company hopes to win final FDA approval in 2014.

© HealthDay

1Like our page
Testing of renal deactivation, a minimally invasive way to treat drug-resistant high blood pressure, is under way, and Food and Drug Administration approval could come in 2014.
drug-resistant high blood pressure,high blood pressure control,renal deactivation,hypertension,kidneys and high blood pressure,Dr. Chauncey Crandall
Wednesday, 25 April 2012 09:50 AM
Newsmax Media, Inc.

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved